The nuclear matrix: Involvement in replication, transcription gene splicing and cellular regulation
R. Davie,Jian‐Min Sun,H. Chen,Wei Li,Michael J Hendzel,Debbie Chadee,William R. Taylor,Jim A. Wright,C. D. Allis3,Peter B. Becker,T. Blank,Catherine Mitchelmore,Raphael Sandaltzopoulos,Gay1 Wall,P. Varga-Weisz
DOI: https://doi.org/10.1002/jcb.240590705
Abstract:. During embryogenesis, cell-cell interaction molecules trigger signal transduction pathways that affect cell movements and adhesion, cell growth and death and the accumulation of extracellular matrix (ECM). These cell behaviors result in the mechanical changes recognized as change in tissue form. This morphogenesis is recapitulated, at least in part, during the repair of injured tissues. Both morphogenesis and wound repair are accompanied by the selective induction of members of the syndecan family of transmembrane proteoglycans. These four proteoglycans in mammals, the predominant source of the heparan sulfate that is ubiquitous at cell surfaces, are ancient molecules that arose by gene duplication and divergent evolution from a single ancestral proteoglycan. The heparan sulfate chains bind a variety of cell-cell interaction molecules (e.g. growth factors (GF), GF-binding proteins, ECM components, chemokines, cell adhesion molecules, degradative enzymes and protease inhibitors). At the cell surface they mediate the action of these ligands by acting directly as receptors or, more often, as coreceptors in concert with ligand-specific receptors. Although binding is widespread, the syndecans show selectivity: different tissues have a distinctive syndecan repertoire (epithelia and plasma cells express predominantly syndecan-1; endothelia, syndecan-2; neural and neural crest, syndecan-3; and nearly all cells, syndecan-4), and syndecans from different cell types vary in the size, fine structure and ligand-binding specificity of their heparan sulfate chains. In addition to the autocrine action of cell surface syndecans, the syndecan extracellular domains (ectodomains) are shed intact from the cell surface and act as paracrine effectors. The syndecan-1 ectodomain stimulates cell proliferation with aFGF and bFGF, but inhibits with HB-EGF, effects due to distinct heparan Sulfate regions: the growth stimulation involves highly sulfated regions and the growth inhibition involves less extensively sulfated regions. The syndecans also have intracellular actions; loss of syndecan-I expression causes epithelia to become mesenchyme-like and to lose anchorage independent growth. Syndecan expression in embryos follows morphogenetic rather than histologic boundaries. Syndecan-1 appears in the preimplantation embryo, syndecan-3 during neurulation, and syndecan-2 and -4 appear later, during organogenesis. Syndecan-I is induced during epithelial-mesenchymal interactions, and syndecan-1 and -4 are transiently induced in capillaries and fibroblasts at the edges of repairing dermal wounds. The latter induction can be due to synducin, a 39 amino acid proline and arginine-rich peptide that is identical to PR-39, a previously described antibacterial peptide. SynducidPR-39 is derived from the wound leukocytes, and its propeptide is nearly identical to that of bac-5 and bac-7, antibacterial peptides from bovine neutrophils. Antibacterial and syndecan inductive concentrations are identical, suggesting that leukocytes deposit into wounds a peptide that both induces adjacent mesenchymal cells to express syndecans as part of the repair process and kills invading bacteria as part of a non-immune host defense mechanism. Thus, by several mechanisms, syndecan expression regulates morphogenetic cell behavior.